Cited 0 time in
Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 cells
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Shin, Incheol | - |
| dc.contributor.author | Arteaga, Carlos L. | - |
| dc.date.accessioned | 2022-12-21T09:59:45Z | - |
| dc.date.available | 2022-12-21T09:59:45Z | - |
| dc.date.issued | 2006-11 | - |
| dc.identifier.issn | 1521-6543 | - |
| dc.identifier.issn | 1521-6551 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/180816 | - |
| dc.description.abstract | We investigated the effect of constitutive active Akt expression on anti-proliferative and apoptotic effect of tamoxifen in MCF-7 human breast cancer cells. Forced expression of Akt(DD) (T308D, S473D) resulted in increased phosphorylation of GSK3 beta, a physiological substrate of Akt. When estrogen receptor (ER) mediated transcription was determined by luciferase assays, there was more than 2-fold increase in estradiol-dependent transcription in MCF-7 cells overexpressing Akt(DD) (MCF-7 Akt(DD)) compared to vector control cells (MCF-7 vec). MCF-7 Akt(DD) cells showed increased proliferation in a medium containing charcoal stripped serum supplemented with estradiol. When the cell cycle profiles were examined, there was an increase in S-phase and a reduction in G1 phase in MCF-7 Akt(DD) cells as compared to MCF-7 vec cells. Overexpression of Akt(DD) also attenuated tamoxifen-mediated apoptosis. These results suggest that Akt could confer resistance to anti-estrogen mediated cell death and inhibition of proliferation. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Taylor & Francis | - |
| dc.title | Expression of active Akt protects against tamoxifen-induced apoptosis in MCF-7 cells | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1080/15216540601001681 | - |
| dc.identifier.scopusid | 2-s2.0-33750624634 | - |
| dc.identifier.wosid | 000241794200007 | - |
| dc.identifier.bibliographicCitation | IUBMB Life, v.58, no.11, pp 664 - 669 | - |
| dc.citation.title | IUBMB Life | - |
| dc.citation.volume | 58 | - |
| dc.citation.number | 11 | - |
| dc.citation.startPage | 664 | - |
| dc.citation.endPage | 669 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Cell Biology | - |
| dc.subject.keywordPlus | ESTROGEN-RECEPTOR-ALPHA | - |
| dc.subject.keywordPlus | SIGNALING NETWORK | - |
| dc.subject.keywordPlus | PHOSPHORYLATION | - |
| dc.subject.keywordPlus | KINASE | - |
| dc.subject.keywordPlus | P27(KIP1) | - |
| dc.subject.keywordPlus | OVEREXPRESSION | - |
| dc.subject.keywordPlus | AMPLIFICATION | - |
| dc.subject.keywordPlus | INHIBITION | - |
| dc.subject.keywordPlus | ACTIVATION | - |
| dc.subject.keywordPlus | RESISTANCE | - |
| dc.subject.keywordAuthor | tamoxifen | - |
| dc.subject.keywordAuthor | Akt signaling | - |
| dc.subject.keywordAuthor | breast cancer cells | - |
| dc.identifier.url | https://iubmb.onlinelibrary.wiley.com/doi/abs/10.1080/15216540601001681 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
